Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy

Reproductive BioMedicine Online

Volumn 16, Issue 6, 2008, Pages 898-905

  Ilchim, Thomas E ^a   Solano, Fabio ^b   Brenes, Roberto ^b   Glenn, Eduardo ^b   Chang, Junbiao ^c   Chan, Kyle ^a   Riordan, Neil ^a,c  

^a MediStem Laboratories Inc   (United States)

^b Institute for Cellular Medicine   (Costa Rica)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Angiogenesis; CD34; Cord blood; Dilated cardiomyopathy; Mesenchymal; Stem cell therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; AMLODIPINE BESYLATE; CARNITINE; CARVEDILOL; HYDROCHLOROTHIAZIDE; MAGNESIUM; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RIBOSE; UBIDECARENONE; VALSARTAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL AGING; CELL POPULATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORD BLOOD STEM CELL TRANSPLANTATION; CROHN DISEASE; DIET SUPPLEMENTATION; GRAFT VERSUS HOST REACTION; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; INHIBITION KINETICS; MEDICAL RESEARCH; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDITIS; NONHUMAN; PATIENT SAFETY; PLACENTA; STEM CELL; TISSUE REGENERATION; TREATMENT OUTCOME;

EID: 41049098391     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)60159-9     Document Type: Article

References (103)

1. Adler S, Singhal SK, Sercarz EE. 1976 Regulatory cells in the bone marrow. Advances in Experimental Medicine and Biology 66, 599-605.
2. Arguero R, Careaga-Reyna G, Castaño-Guerra R et al. 2006 Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Archives of Medical Research 37, 1010-1014.
3. Assmus B, Honold I, Schächinger V et al. 2006 Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine 355, 1222-1232.
4. Assmus B, Schächinger V, Teupe C et al. 2002 Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017.
5. Bachmaier, K, Penninger JM 2005 Chlamydia and antigenic mimicry. Current Topics in Microbiology and Immunology 296, 153-163.
6. Baumgarten G, Knuefermann P, Kalra D et al. 2002 Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation 105, 2192-2197.
7. Beeres SL, Bax JJ, Dibbets-Schneider P et al. 2006 Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results. American Heart Journal 152, 684 e11-16.
8. Beeson, D, Lippman A 2006 Egg harvesting for stem cell research: medical risks and ethical problems. Reproductive BioMedicine Online 13, 573-579.
9. Berry MF, Englet AJ, Woo WJ et al. 2006 Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. American Journal of Physiology Heart and Circulatory Physiology. 290, H2196-H2203.
10. Blanco Pampin J, Garcia Rivera SA, Otero Cepeda XL et al. 2006 Immunohistochemical expression of HIF-1alpha in response to early myocardial ischemia. Journal of Forensic Sciences 51, 120-124.
11. Boomsma RA,, Swaminathan PD, Geenen DL et al. 2006 Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. International Journal of Cardiology 122, 17-28.
12. Briguori C, Reimers B, Sarais C et al. 2006 Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. American Heart Journal 151, 674-680.
13. Brooksbank R, Woodiwiss A, Sliwa K et al. 2005 Sustained white cell cytokine activation in idiopathic dilated cardiomyopathy despite haemodynamic improvement with medical therapy. Cardiovascular Journal of South Africa 16, 200-204.
14. Cailleret M, Amadou A, Andrieu-Abadie N et al. 2004 N-Aacetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes. Circulation 109, 406-411.
15. Chen QM, Tu VC 2002 Apoptosis and heart failure: mechanisms and therapeutic implications. American Journal of Cardiovascular Drugs 2, 43-57.
16. Chen SL, Fang WW, Qian J et al. 2004 Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chinese Medical Journal 117, 1443-1448.
17. 2- production. Journal of Thrombosis and Haemostasis 90, 317-325.
18. Deng ZR, Yang C, Ma AQ et al. 2006 (Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction]. Nan Fang Yi Ke Da Xue Xue Bao 26, 1637-1640.
19. Direskeneli H, Saruhan-Direskeneli G 2003 The role of heat shock proteins in Behçet's disease. Clinical and Experimental Rheumatology 21, S44-48.
20. Djouad F, Fritz V, Apparailly F et al. 2005 Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis and Rheumatism 52, 1595-1603.
21. Edwards RG, Hollands P 2007 Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Reproductive BioMedicine Online 14, 396-401.
22. Eisenberg CA, Burch JB, Eisenberg LM 2006 Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. Stem Cells 24, 1236-1245.
23. Fernandez-Aviles F, San Roman JA, García-Frade J et al. 2004 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circulation Research 95, 742-748.
24. Findikli N, Candan NZ, Kahraman S 2006 Human embryonic stem cell culture: current limitations and novel strategies. Reproductive BioMedicine Online 13, 581-590.
25. Frangogiannis NG, Entman ML 2006 Identification of mast cells in the cellular response to myocardial infarction. Methods in Molecular Biology 315, 91-101.
26. Frangogiannis NG, Smith CW, Entman ML 2002 The inflammatory response in myocardial infarction. Cardiovascular Research 53, 31-47.
27. Frantz, S, Kobzik L, Kim YD et al. 1999 Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. Journal of Clinical Investigation 104, 271-280.
28. Fuchs S, Satler LF, Kornowski R et al. 2003 Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. Journal of the American College of Cardiologists 41, 1721-1724.
29. Fuenmayor C, Higuchi ML, Carrasco H et al. 2005 Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Acta Cardiologica 60, 33-37.
30. Fuse K, Chan G, Liu Y et al. 2005 Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112, 2276-2285.
31. Gao LR, Wang ZG, Zhu ZM et al. 2006 Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. American Journal of Cardiology 98, 597-602.
32. Ghen MJ, Roshan R, Roshan RO et al. 2006 Potential clinical applications using stem cells derived from human umbilical cord blood. Reproductive BioMedicine Online 13, 562-572.
33. Gnecchi M, He H, Noiseux N et al. 2006 Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB Journal 20, 661-669.
34. Guo J, Lin CS, Bao CY et al. 2007 Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 30, 97-104.
35. Hamano K, Nishida M, Hirata K et al. 2001 Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Japanese Circulation Journal 65, 845-847.
36. Hasper D, Hummel M, Kleber FX et al. 1998 Systemic inflammation in patients with heart failure. European Heart Journal 19, 761-765.
37. Heeschen C, Lehmann R, Honold J et al. 2004 Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109, 1615-1622.
38. Ibe W, Saraste A, Lindemann S et al. 2007 Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment. European Journal of Heart Failure 9, 160-167.
39. Iwakura A, Fujita M, Ikemoto M et al. 2000 Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid. Heart Vessels 15, 112-116.
40. Jeremias I, Kupatt C, Martin-Villalba A et al. 2000 Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102, 915-920.
41. Kalivendi SV, Konorev EA, Cunningham S et al. 2005 Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochemistry Journal 389, 527-539.
42. Kang HJ, Lee HY, Na SH et al. 2006 Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 (Suppl. 1), I145-I151.
43. Karkkainen S, Peuhkurinen K 2007 Genetics of dilated cardiomyopathy. Annals of Medicine 39, 91-107.
44. Kasper EK, Agema WR, Hutchins GM et al. 1994 The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. Journal of the American College of Cardiology 23, 586-590.
45. Katritsis DG, Sotiropoulou PA, Karvouni E et al. 2005 Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheterization and Cardiovascular interventions 65, 321-329.
46. Kern S, Eichler H, Stoeve J et al. 2006 Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301.
47. Kietselaer BL, Reutelingsperger CP, Boersma HH et al. 2007 Noninvasive detection of programmed cell loss with 99mTc-labelled annexin A5 in heart failure. Journal of Nuclear Medicine 48, 562-567.
48. Kudo M, Wang Y, Wami MA et al. 2003 Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. Journal of Molecular and Cellular Cardiology 35, 1113-1119.
49. Lee RH, Seo MJ, Reger RL et al. 2006 Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/SCID mice. Proceedings of the National Academy of Sciences of the USA 103, 17438-17443.
50. Leone AM, Rutella S, Bonanno G et al. 2006 Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. International Journal of Cardiology 111, 202-208.
51. Li D, Zhao L, Liu M et al. 1999 Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. American Heart Journal 137, 1145-1152.
52. Li H, Guo ZK, Li XS et al. 2007 Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model. Cell Transplantation 16, 85-95.
53. Li W, Gan R, Sun G 2002 Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling. Chinese Medical Journal 115, 1166-1169.
54. Li ZQ, Zhang M, Jing YZ et al. 2007 The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology 115, 52-56.
55. Liao X, Wang X, Gu Y et al. 2005 Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sciences 77, 160-174.
56. Middel B, Bouma J, de Jongste M et al. 2001 Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Clinical Rehabilitation 15, 489-500.
57. Moe GW, Marin-Garcia J, Konig A et al. 2004 In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. American Journal of Physiology Heart and Circulatory Physiology 287, H1813-20.
58. Mollmann H, Nef HM, Kosin S et al. 2006 Bone marrow-derived cells contribute to infarct remodelling. Cardiovascular Research 71, 661-671.
59. Moore SC, Shaw MA, Soderberg LS. 1992 Transforming growth factor-beta is the major mediator of natural suppressor cells derived from normal bone marrow. Journal of Leukocyte Biology 52, 596-601.
60. Musina RA, Bekchanova ES, Belyavskii AV, Sukhikh GT 2006 Differentiation potential of mesenchymal stem cells of different origin. Bulletin of Experimental Biology and Medicine 141, 147-151.
61. Nagaya N, Kangawa K, Itoh T et al. 2005 Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128-1135.
62. Nitobe J, Yamaguchi S, Okuyama M et al. 2003 Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovascular Research 57, 119-128.
63. Nozaki N, Shishido T, Takeishi, et al. 2004 Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 110, 2869-2874.
64. O'Neill LA 2002 Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends in Immunology 23, 296-300.
65. Obradovic S, Rusovic S, Balint B et al. 2004 Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction. Vojnosanit Pregl 61, 519-529.
66. Oral H, Fisher SG, Fay WP et al. 1999 Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 83, 388-391.
67. Orea-Tejeda A, Arrieta-Rodriguez O, Castillo-Martínez L et al. 2006 Effects of thalidomide treatment in heart failure patients. Cardiology 108, 237-242.
68. Orlic D 2003 Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Annals of the New York Academy of Sciences USA 996, 152-157.
69. Orlic D, Kajstura J, Chimenti S et al. 2001 Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705.
70. Osterziel KJ 2007 Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. European Heart Journal 28, 638.
71. Ozbaran M, Omay SB, Nalbantgil S et al. 2004 Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. European Journal of Cardiothoracic Surgery 25, 342-50; discussion 350-1.
72. Pan JP, Liu TY, Chiang SC et al. 2004 The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure. Journal of the Chinese Medical Association 67, 222-228.
73. Patel AN, Geffner L, Vina RF et al. 2005 Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. Journal of Thoracic and Cardiovascular Surgery 130, 1631-1638.
74. Paulus WJ 2000 Cytokines and heart failure. Heart Failure Monitor 1, 50-56.
75. Rauchhaus M, Koloczek V, Volk H et al. 2000 Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. International Journal of Cardiology 76, 125-133.
76. Richardson P, McKenna W, Bristow M et al. 1996 Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93, 841-842.
77. Rodas A, Toro S, Ramos A et al. 1992 [The incidence of Trypanosoma cruzi antibodies in patients with dilated myocardiopathy at the Instituto Nacional de Cardiologia Ignacio Chavez]. Archives of the Institute of Cardiology of Mexico 62, 541-545.
78. Roncon-Albuquerque RJ, Vasconcelos M, Lourenço AP et al. 2005 Activation profile of pro-inflammatory cytokines in acute cardiac overload. Revista Portuguesa de Cardiologia 24, 1369-1378.
79. Samstein B, Johnson GB, Platt JL 2004 Toll-like receptor-4 and allograft responses. Transplantation 77, 475-477.
80. Satoh M, Shimoda Y, Akatsu T et al. 2006a Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. European Journal of Heart Failure 8, 810-815.
81. Satoh M, Shimoda Y, Maesawa C et al. 2006b Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. International Journal of Cardiology 109, 226-234.
82. Schachinger V, Assmus Britten MB et al. 2004 Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology 44, 1690-1699.
83. Schomig K, Busch G, Steppich B et al. 2006 Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. European Heart Journal 27, 1032-1037.
84. Seko Y, Kayagaki N et al. 2002 Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. Journal of the American College of Cardiology 39, 1399-1403.
85. Shintani S, Murohara T, Ikeda H et al. 2001 Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-2779.
86. Shishido T, Nozaki N, Yamaguchi S et al. 2003 Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108, 2905-2910.
87. Shyu KG, Wang BW, Hung HF et al. 2006 Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. Journal of Biomedical Sciences 13, 47-58.
88. Sliwa K, Woodiwiss A, Kone VN et al. 2004 Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 109, 750-755.
89. Soares MB, Silva-Mota KN, Lima RS et al. 2001 Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. American Journal of Pathology 159, 703-709.
90. Soeki T, Tamura Y, Shinohara H et al. 2000 Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease. Heart Vessels 15, 105-111.
91. Song H, Tasaki H, Yashiro A et al. 2001 Dilated cardiomyopathy and Chlamydia pneumoniae infection. Heart 86, 456-458.
92. Spotnitz MD, Lesch M 2006 Idiopathic dilated cardiomyopathy as a late complication of healed viral (coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. Progress in Cardiovascular Diseases 49, 42-57.
93. Stamm C, Kleine HD, Choi YH et al. 2007 Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. Journal of Thoracic and Cardiovascular Surgery 133, 717-725.
94. Talvani A, Rocha MO, Barcelos LS et al. 2004 Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clinical Infectious Diseases 38, 943-950.
95. Tang J, Xie Q, Pan G et al. 2006 Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. European Journal of Cardiothoracic Surgery 30, 353-361.
96. Thomas JA, Haudek SB, Koroglu T et al. 2003 IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. American Journal of Physiology Heart and Circulatory Physiology 285, H597-H606.
97. Tse HF, Siu CW, Zhu SG et al. 2007 Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. European Journal of Heart Failure 9, 747-753.
98. van de Stolpe A, van den Brink S, van Rooijen M et al. 2005 Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line. Reproductive BioMedicine Online 11, 476-485.
99. Wollert KC, Meyer GP, Lutz J et al. 2004 Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429), 141-148.
100. Xu M, Wani M, Dai YS et al. 2004 Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110, 2658-2665.
101. Yaoita H, Takase S, Maruyama Y et al. 2005 Scintigraphic assessment of the effects of bone marrow-derived mononuclear cell transplantation combined with off-pump coronary artery bypass surgery in patients with ischemic heart disease. Journal of Nuclear Medicine 46, 1610-1617.
102. Yasuda M, Takeuchi K, Hiruma et al. 1990 The complement system in ischemic heart disease. Circulation 81, 156-163.
103. Zappia E, Casazza S, Pedemonte E et al. 2005 Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761.